The gas hydrogen sulphide (H 2 S) is normally produced in large amounts in the central nervous system during the metabolism of sulphur-containing aminoacids. H 2 S was recently shown to influence long-term potentiation in the rat hippocampus; this finding suggested that the gas may act as a neuromodulator in the brain. We therefore tested the effect of the gas on the release of corticotropin-releasing hormone (CRH) from rat hypothalamic explants. CRH immunoreactivity in the incubation media was taken as a marker of peptide release. We found that the addition of NaHS to incubation media was consistently associated with a concentration-dependent decrease in KClstimulated CRH release, whereas basal secretion was unaffected. Increased endogenous H 2 S production may be also obtained using an indirect precursor of H 2 S formation, S-adenosyl-lmethionine (SAMe). The latter mimicked the effects of NaHS, since it reduced potassium-stimulated CRH release. In vivo, SAMe showed no effect on hypothalamo-pituitary-adrenal (HPA) function under resting conditions, but inhibited stress-related glucocorticoid increase.
While carbon monoxide has long been thought to be a mere ies appear to be low (5). CbS is markedly activated by S-adenosyl--methionine (SAMe) (3, 6). The latter is a pivotal by-product of heme catabolism, only recently it has been found to play a role as a neuromodulator in the central and cofactor in transmethylation and transulphuration reactions, which account for the metabolism of about 66% of total peripheral nervous system (1). Similarly nitric oxide (NO), a gaseous compound with pleiotropic biological activities, can SAMe administered in vivo to rats (7). Another enzymatic pathway is based on the ability of CSE be considered a by-product of -arginine catabolism through the NO-synthase pathway (2). A similar scenario is now to degrade cysteine, yielding pyruvate, NH 3 and H 2 S. CSE also transforms cystine into thiocysteine; the latter enters the emerging for by-products of sulphur-containing aminoacid metabolism, which may generate the gaseous compound, so-called thiosulphate cycle, which gives rise to H 2 S and other inorganic sulphur compounds through non enzymatic hydrogen sulphide (H 2 S). In contrast to the situations with carbon monoxide and conversion in the presence of glutathione (8). Finally, H 2 S can be generated by enzymatic desulphuration of b-NO, there is not a single enzymatic activity leading to H 2 S generation but various enzymatic and non enzymatic pathmercaptopyruvate, which derives from cysteine transamination (9). As a result of the above reactions, extremely large ways appear to be involved (Fig. 1) . One pathway is based on cystathionine-b-synthase (CbS, EC 4.2.1.22) (3), which amounts of H 2 S are produced in the central nervous system (CNS) under basal conditions; 1.57 and 0.67 mg/g in the converts homocysteine to cystathionine. The latter is subsequently transformed to cysteine by cystathionine-c-lyase whole brain and midbrain of rat and humans are detected by the gas dialysis-ion chromatography technique (10). (CSE, EC 4.4.1.1) (4). CbS also hydrolizes cysteine, producing equimolar amounts of serine and H 2 S; this reaction is Although the endogenous generation of H 2 S is a well known phenomenon, only recently have Abe and Kimura reversible in the presence of low cysteine concentrations or during foetal development, when liver and brain CSE activitshown that the gas is associated with biological activity:
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Ldt, Italy), 60 mg/ml ascorbic acid (Sigma) and 100 IU/ml aprotinin concentrations of H 2 S in the physiological range are reported ( TrasylolB, Bayer, Germany), pH 7.4, in an atmosphere of O 2 5CO 2 to facilitate long-term potentiation in the rat hippocampus, (95%55%).
whereas higher levels interfere with neuronal excitability (11).
After 80 min of preincubation, explants were subjected to a 20-min control H 2 S has also been shown to potentiate the relaxing effect of incubation in plain medium to assess basal CRH release. 
Materials and methods
of the third day, 1 h after the fifth treatment, rats were killed, the trunk blood collected and stored at −30°C until assay for corticosterone and arginine Animals vasopressin immunoreactivity. Male Wistar rats weighing 200-250 g were used. They were kept five to a cage and maintained at a temperature of 21±1.5°C, with relative humidity Electron microscopy of 65±2%. The animals were exposed to 12 h of light (06.00 a.m./06.00 p.m.) Hypothalamic slices were prefixed by immersion in Karnosky fixative in 0.1  followed by 12 h of dark, and had free access to food and water. The use of phosphate buffered saline (PBS ), pH 7.4 for 1 h, washed twice with PBS plus animals for this experimental work has been approved by the Italian Ministry 3% sucrose and then postfixed in 1% osmium tetroxide for 30 min, dehydrated of Health ( licensed authorization to P. Navarra).
in graded ethanol and embedded in EPON 812. Sections were then stained In vitro studies with uranyl acetate and lead citrate and examined in a Philips EM 400 transmission electron microscope.
Hypothalamic dissection
On the day of the experiment, the animals were decapitated between 09.00
Analytical methods and 10.00 a.m. to avoid circadian variations. The brains were removed, and the hypothalami were dissected within the following limits: posterior border CRH assay of the optic chiasm, anterior border of the mamillary bodies, and the lateral CRH was measured by radioimmunoassay ( RIA) as previously described hypothalamic sulci. The depth of dissection was 4 mm. The hypothalami were (16) , with modifications. A CRH antiserum kindly provided by Professor then bisected longitudinally through the mid-sagittal plane, and two hypothalRenato Bernardini, and (2-[125I ]-iodohystidyl32)-CRH (Amersham Pharmacia amic halves from the same animal were incubated in the same vial. The total Biotech, Little Chalfont, Buckinghamshire, UK ) were used. The lower dissection time was less than 2 min from decapitation. This procedure detection limit of the assay was 1 pg/tube (100 ml sample volume), with intramaintains the anatomical integrity of CRH neurone pathway, which ranges and interassay coefficients of variation of 5% and 10%, respectively. from the paraventricular nuclei of the hypothalamus to the median eminence. This enables to observe possible effects of the test substances mediated via Corticosterone assay interaction at the level of cell bodies, which may differ from those on nerve Serum corticosterone was measured by RIA (18) . The detection limit of the terminals at the median eminence (16) . assay was 2 pg/ml and the IC 50 of the standard curve 20 pg/ml.
Hypothalamic incubation
Arginine vasopressin assay Two hypothalamic halves from the same animal were incubated in 7-ml polyethylene vials in a shaking bath at 37°C. Each vial contained 450 ml Arginine vasopressin was measured by RIA as previously described (19) . The detection limit of the assay was 0.5 pg/ml, with intra-and interassay coeffiincubation medium, Earle's Balanced Salt Solution ( EBSS, Gibco Biocult, Paisley, UK ) supplemented with 0.2% human serum albumin (Sigma-Aldrich cients of variation of 5% and 7%, respectively.
F. 1. The scheme shows the complex series of enzymatic and non-enzymatic reactions involved in H 2 S generation.
(1) S-adenosylmethionine synthetase (methionine adenosyltransferase); (2) representative of transmethylation reactions; (3) adenosyl-homocysteinase; (4) cystathionine-bsynthase (CbS ); (5) cystathionine-c-lyase (CSE); (6) cysteine aminotransferase; (7) representative of enzymatic desulphuration reactions involving bmercaptopyruvate; (8) methyl-tetrahydrofolate-homocysteine methyltransferase (methionine synthase); (9) betaine-homocysteine methyltransferase. FH 4 =tetrahydrofolic acid. GSH=reduced glutathione. GSSG=oxidized glutathione. SSO 3 2−=thiosulphate. Cys=cysteine.
LDH assay T 1. NaHS inhibits KCl-stimulated CRH Release in a
The assay was performed using a commercial kit (Abbott S. 11). NaHS in the range 0.1-10 m did not affect basal CRH release (Fig. 2) . Subsequent 20-min incubations in medium containing 56 m KCl, carried out to estimate residual CRHvs Controls and P<0.05 vs KCl alone), and could not be used to revert the effects of H 2 S. releasing ability of the tissues, revealed that peptide secretion was impaired in those hypothalami previously treated with Since high concentrations of H 2 S are associated with toxic effects on certain biochemical activities in the cell (10, 22), the highest NaHS concentration ('post-washout effect') ( Fig. 2) . functional and morphological assessment of possible damage caused by NaHS were carried out. LDH leakage from In contrast to the findings on basal release, NaHS inhibited in a concentration-dependent manner KCl-stimulated CRH hypothalamic explants was taken as a functional index of cytotoxicity. These experiments showed that higher LDH release, with significant reductions obtained with both 1 m and 10 m (Table 1) . We also attempted to antagonize the ratios (see Materials and Methods) are more frequently associated with 10 m NaHS (Table 2) , but elevated LDH effects of H 2 S by using a H 2 S-chelating system consisting of a Hb-Ao solution additioned with phenylhydroxylamine (21) .
release was also observed in a control hypothalamus. Electron microscopy on hypothalami treated for 20 min However, this chelating system interfered per se with CRH release (data expressed as CRH ratio, means±SEM of (n) with 56 m KCl alone or in the presence of 10 m NaHS showed no clear necrotic or apoptotic cell death. Mild signs replicates per group. Controls: 0.944±0.12 (6); 56 m KCl: 5.714±1.1 (6), P<0.05 vs Controls; 56 m KCl+10 m of neuronal damage, including mitochondrial swelling and condensation and marginalization of nuclear chromatin, were Hb+40 m phenylhydroxylamine: 10.602±1.7 (8), P<0.001 EBSS; 0.1mM NaHS; 1mM NaHS; 10mM NaHS; 56mM KCl.
F. 2. Graded concentrations of NaHS do not modify basal CRH release after 20 min of incubation. However, the highest NaHS dose (10 m) appears to impair residual CRH-releasing ability of the hypothalamic explants, since subsequent 20-min treatments with 56 m KCl are associated with reduced release from the group previously treated with 10 m NaHS. Data are expressed as pg CRH/hypothalamus, means±SEM of 7-9 hypothalami per group.
T 2. Levels of LDH Activity in Homogenates and release. While addition of both substances tended to counteract the effect of SAMe, the reversal did not attain statistical Incubation Media from Each Hypothalamic Incubation. significance (Table 3) . the vehicle by the same route. However, this effect showed desensitization, since it was not observed in rats receiving SAMe for a total of five treatments (Fig. 5) . Rats receiving observed in both controls and NaHS-treated hypothalami (Fig. 3, , upper panels), with no obvious effect of NaHS repeated SAMe treatments had significantly lower increases in serum corticosterone levels compared to controls after 1-h per se. Thus, variations in peptide release associated with the treatments (as shown in the lower panels of Fig. 3) do not exposure to 4°C (Fig. 6 ). Since corticosterone levels may reflect the action of various corticotropin-releasing factors appear to be correlated with any morphological change in the tissues.
and not only CRH, in this experiment we also measured circulating arginine vasopressin. Unlike corticosterone, the increase in arginine vasopressin levels after 1-h exposure to In vitro experiments with SAMe 4°C did not attain statistical significance (data expressed as pg arginine vasopressin/ml of serum, means±SEM of (n) Subsequent experiments were addressed to investigate whether increases in endogenous H 2 S production can mimic replicates per group. Controls at 20°C: 0.81±0.22 (7); rats taken at 4°C: 1.34±0.38 (8); rats taken at 4°C+SAMe, the effects of exogenous additions of the gas. Similar to NaHS, SAMe was able to inhibit KCl-stimulated CRH 100 mg/kg twice daily per 2 days: 1.44±0.34 (7)). Although circulating arginine vasopressin levels reflect production by release, with statistical significance at 1 m (Fig. 4) . We also attempted to revert the effect of SAMe with the concurrent paraventricular nuclei magnocellular neurones, and therefore are not a specific index of arginine vasopressin production addition of AOAA, a putative inhibitor of CbS, or BCLA, which inhibits CSE. These compounds were given alone at by parvocellular neurones secreting into the hypophyseal portal circulation, the present data suggest that the inhibitory 0.1 m, a concentration able to significantly reduce H 2 S production in vitro (11, 12). Each of the inhibitors failed to action of SAMe on corticosterone might depend on selective inhibition of CRH release. counteract SAMe-induced inhibition of stimulated CRH 
The other tool used in this study, SAMe, was shown to be a better precursor than methionine in transsulphuration and demethylation reactions (7), and could also be used in vivo to confirm in-vitro findings (see below). -cysteine, one other direct precursor of H 2 S production through CbS and/or CSE (Fig. 1, steps 4 and 5) could not be used because of instability and evidence of neuronal toxicity in vitro (23) . SAMe has been shown to increase gas production in rat brain homogenates (11): this effect is secondary to SAMe involvement in various enzymatic activity, in particular as a CbS activator (3), leading to H 2 S generation (Fig. 1) . Apart from H 2 S Single treatment Corticosterone, ng/ml a number of which have been attributed to its methyl donor properties (24) . One such reaction involving the transfer of methyl groups, which might interfere with CRH release in the hypothalamus, is conversion of norepinephrine to epinephrine by phenyl-ethanolamine-N-methyl-transferase (PNMT ). However, any possible effect of epinephrine on CRH release in vitro is likely to be a stimulation (25) , thereby excluding a role for PNMT in the present effect of SAMe. Another possible effect induced by SAMe in the rat and human hypothalamus is the increase of serotonin turnover (26) , but this neurotransmitter has also been shown to stimulate CRH release in our model (27) . Taken collectively, these data and the present finding that SAMe mimics the action of the H 2 S-donor NaHS suggest that the effects of SAMe on CRH release are more likely associated with its H 2 S-forming ability rather than methyl donor activity. While by a specific synthetase (29) and is found in different areas of rat brain, including the hypothalamus (22.2±0.9 nmol/g Discussion of tissue) (30). Interestingly, the gene expression and synthesis of SAMe synthetase have been recently shown to be In this study we found that increases in H 2 S tissue levels, obtained with H 2 S-enriched media or with an endogenous up-regulated by glucocorticosteroids (31) . AOAA and BCLA were claimed to be selective inhibitors precursor of H 2 S biosynthesis, SAMe, are consistently associated with reductions in K+-stimulated CRH release from rat of CbS and CSE, respectively, and were therefore used to inhibit H 2 S production in rat brain homogenates additioned hypothalamic explants in acute experiments. In vivo findings with SAMe reflected in vitro observations, showing no effect with 10 m -cysteine (11). In this experimental paradigm, AOAA but not BCLA was able to reduce H 2 S generation. on basal glucocorticoid release but inhibition over stressinduced activation of the HPA axis.
In contrast, BCLA but not AOAA inhibited H 2 S production in smooth muscle cell homogenates from gastrointestinal or A major drawback in studying the neuroendocrine actions of H 2 S lies on the complexity of enzymatic and non enzymatic vascular tissues (12). Regardless of whether they were tested on CNS or other tissues, the above substances were able to pathways leading to gas production, compared to the simple one-step reactions generating the other two gaseous neuroreduce H 2 S production only if used in high concentrations (up to 5 m) in noncellular systems. The above inconsistencies transmitters, NO and carbon monoxide. Such complexity caused serious difficulties in inhibiting H 2 S synthesis in our might depend on the lack of a sufficient degree of selectivity of these tools. In fact, both AOAA and BCLA are thought experimental model; on the contrary, it was relatively easy to induce increases in gas production. We used incubation media to be nonspecific inhibitors of a number of pyridoxal phosphate-dependent enzymes (32, 33). Apart from the lack of additioned with NaHS; the latter dissociates to Na+ and HS− once in solution; then HS− associates with H+ produspecificity, a major concern is represented by severe neurotoxicity displayed by both compounds. Indeed, BCLA is a major cing H 2 S which, because of high liposolubility (10), diffuses rapidly through the tissues. NaHS has been the preferred causative agent for neurotoxicity during poisoning by Vicia Sativa (neurolathyrism), probably based on excitotoxic mechagent to increase H 2 S production by the majority of investigators (11). In our model, NaHS solutions allow for more anisms (34), whereas AOAA was found to produce seizures and cortical and hippocampal lesions, also attributed to accurate titration compared to direct bubbling of H 2 S in the excitotoxicity (35). In our model, concentrations of the above While an admittedly non-specific tool, SAMe can be used in vivo to increase H 2 S production, whereas a similar use of two inhibitors up to 0.1 m failed to inhibit the relevant enzymatic activities in the hypothalamus. However, considNaHS was prevented by severe systemic toxicity (10). Indeed, SAMe is well tolerated, and has been used with some efficacy eration of the lack of specificity and concern with the risk of toxicity prevented us from testing concentrations higher than in the treatment of depressive disorders (38). In preliminary experiments, SAMe was reported to increase plasma levels of 0.1 m. Unfortunately, to our knowledge no approach is currently available to abolish or even partially counteract the ACTH and corticosterone in the rat, but it reduced their release in response to stress (39). However, to our knowledge fraction of H 2 S production arising from non-enzymatic processes (Fig. 1) . Thus, the issue of blocking H 2 S generation in a full report of this study has never been published. The findings presented here show that such acute increases in such complex experimental paradigm as nervous tissue explants remains unresolved.
corticosterone levels may be a non-specific response which disappears after repeated treatments, whereas more consistent If we are correct that H 2 S generation is able to inhibit CRH release and HPA activity, what is the possible mechanis the inhibitory action of SAMe on HPA function. The latter effect also correlates with reduced CRH release in vitro. While ism(s) underlying such neuroendocrine effects? H 2 S is known to inactivate cytochrome oxidase/cytochrome aa 3 (22), the role of H 2 S in SAMe inhibition on CRH release remains to be clearly established, it is interesting to note that CRH is thereby affecting the respiration and energy-requiring processes of the cell. This mechanism might explain the apparent currently believed to mediate certain symptoms of depressive and anxiety disorders (40) . One might therefore speculate reduction in residual CRH-releasing ability of the hypothalamus after treatment with 10 ('post-washout' effect shown in that the reported antidepressant activity of SAMe, which has been previously attributed to its methyl donor activity (24), Fig. 2 ), but not 1 m NaHS. Thus, the effects of 10 m NaHS in our paradigm seem to reflect a toxic action of the might be also associated with antagonism of CRH secondary to inhibition of peptide secretion. gas. Experiments looking at LDH leakage from hypothalamic tissue confirmed that cell damage is predominantly associated with 10 m NaHS, although the latter, probably because of
